Evidence map›Paper›PMID 41849257›Full record

ArticlePLOS global public health2026

Pursuing policymakers, payors and public - expanding the beginning and end of the tuberculosis care cascade to reflect whole-of-society ambitions.

Luan Nguyen Quang Vo, Ashna Ashesh, Ingrid Schoeman, Obioma Chijioke-Akaniro, Immaculate Kathure, Hoa Binh Nguyen, Anna K Coussens, Hanif Esmail, Rein M G J Houben

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Luan Nguyen Quang VoFriends for International TB Relief, Ha Noi, Viet Nam.ORCID https://orcid.org/0000-0002-5937-6286
Ashna AsheshSurvivors Against TB, Delhi, India.
Ingrid SchoemanTB Proof, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-8982-0878
Obioma Chijioke-AkaniroNational Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Federal Ministry of Health & Social Welfare, Abuja, Nigeria.ORCID https://orcid.org/0000-0001-7906-0521
Immaculate KathureNational Tuberculosis, Leprosy and Lung Disease Program, Ministry of Health, Nairobi, Kenya.
Hoa Binh NguyenNational Tuberculosis Control Programme, National Lung Hospital, Ha Noi, Viet Nam.ORCID https://orcid.org/0000-0002-1543-4907
Anna K CoussensWellcome Discovery Research Platforms in Infection, Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine and Department of Pathology, University of Cape Town, Cape Town, Republic of South Africa.ORCID https://orcid.org/0000-0002-7086-2621
Hanif EsmailUniversity College London, London, United Kingdom.
Rein M G J HoubenTB Modelling Group, TB Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0000-0003-4132-7467

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41849257
PMCPMC12998845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.